Receptor Binding Profiles of Amiloride Analogues Provide no Evidence for a Link Between Receptors and the Na⁺/H⁺ Exchange, But Indicate a Common Structure on Receptor Proteins

References

• Benos D. J. Amiloride: a molecular probe of sodium transport in tissues and cells. Am. J. Physiol. 1982; 242: C131–145
   PubMed Web of Science ®Google Scholar
• Garty H., Benos D. J. Characteristics and regulatory mechanisms of the amiloride-blockable Na+ channel. Physiol. Rev. 1988; 68: 309–373
   PubMed Web of Science ®Google Scholar
• Kleyman T. R., Cragoe E. J., Jr. Amiloride and its analogs as tools in the study of ion transport. J. Membrane Biol. 1988; 105: 1–21
   PubMed Web of Science ®Google Scholar
• Simchowitz L., Cragoe E. J., Jr. Inhibition of chemotactic factor-activated Na+/H+ exchange in human neutrophils by analogues of amiloride: structure-activity relationships in the amiloride series. Mol. Pharmacol. 1986; 30: 112–120
   PubMedGoogle Scholar
• Vigne P., Frelin C., Cragoe E. J., Jr., Lazdunski M. Structure-activity relationships of amiloride and certain of its analogues in relation to the blockade of the Na+/H+ exchange system. Mol. Pharmacol. 1984; 25: 131–136
   PubMed Web of Science ®Google Scholar
• Vigne P., Frelin C., Audinot M., Borsotto M., Cragoe E. J., Jr., Lazdunski M. [3H]Ethylisopropylamiloride, a radio-labelled diuretic for the analysis of the Na+/H+ exchange system. Its use with kidney cell membranes. EMBO J. 1984; 3: 2647–2651
   PubMedGoogle Scholar
• Barbry P., Frelin C., Vigne P., Cragoe E. J., Jr., Lazdunski M. [3H]Phenamil, a radiolabelled diuretic for the analysis of the amiloride-sensitive Na+ channels in kidney membranes. Biochem. Biophys. Res. Comm. 1986; 135: 25–32
   PubMedGoogle Scholar
• Kaczorowski G. J., Barros F., Dethmers J. K., Trumble M. J., Cragoe E. J., Jr. Inhibition of Na+/Ca2+ exchange in pituitary plasma membrane vesicles by analogues of amiloride. Biochemistry 1985; 24: 1394–1403
   PubMedGoogle Scholar
• Friedrich T., Burckhardt G. Inhibition and labeling of the rat renal Na+/H+ exchanger by an antagonist of muscarinic acetylcholine receptors. Biochem. Biophys. Res. Comm. 1988; 157: 921–929
   PubMedGoogle Scholar
• Häussinger D., Brodde O. E., Starke K. Alpha-adrenoceptor antagonistic action of amiloride. Biochem. Pharmacol. 1987; 36: 3509–3515
   PubMedGoogle Scholar
• Howard M. J., Mullen M. D., Insel P. A. Amiloride interacts with renal α- and β-adrenergic receptors. Am. J. Physiol. 1987; 253: F21–25
   Google Scholar
• Howard M. J., Hughes R. J., Motulsky H. J., Mullen M. D., Insel P. A. Interactions of amiloride with α- and β-adrenergic receptors: amiloride reveals an allosteric site on α2-adrenergic receptors. Mol. Pharmacol. 1987; 32: 53–58
   PubMed Web of Science ®Google Scholar
• Isom L. L., Cragoe E. J., Jr., Limbird L. E. Multiple receptors linked to inhibition of adenylate cyclase accelerate Na+/H+ exchange in neuroblastoma x glioma cells via a mechanism other than decreased cAMP accumulation. J. Biol. Chem. 1987; 262: 17504–17509, and (correction) J. Biol. Chem.263 16513, 1988
   PubMed Web of Science ®Google Scholar
• Kuijpers G. A. J., De Pont J. J.H.H.M., van Nooy I. G. P., Fleuren-Jakobs A. M. M., Bonting S. L., Rodrigues De Miranda J. Amiloride is a cholinergic antagonist in the rabbit pancreas. Biochim. Biophys. Acta. 1984; 804: 237–244
   PubMed Web of Science ®Google Scholar
• Martinez J. R., Barker S., Camden J. Amiloride inhibits 22Na+ uptake and [3H]QNB binding in rat submandibular gland cells. Eur. J. Pharmacol. 1989; 164: 335–339
   PubMedGoogle Scholar
• Nunnari J. M., Repaske M. G., Brandon S., Cragoe E. J., Jr., Limbird L. E. Regulation of porcine brain α2 adrenergic receptors by Na+ H+ and inhibitors of Na+/H+ exchange. J. Biol. Chem. 1987; 262: 12387–12392
   PubMed Web of Science ®Google Scholar
• Yablonsky F., Dausse J. P. Amiloride interacts with [3H]idazoxan and [3H]rauwolscine binding sites in rabbit urethra. Eur. J. Pharmacol. 1989; 164: 167–170
   PubMedGoogle Scholar
• Limbird L. E. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J. 1988; 2: 2686–2695
   PubMed Web of Science ®Google Scholar
• Garritsen A., Jzerman A.I. P., Beukers M. W., Cragoe E. J., Jr., Soudijn W. Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain. Biochem. Pharmacol. 1990; 40: 827–834
   PubMedGoogle Scholar
• Cragoe E. J., Jr., Woltersdorf O. W., Jr., Bicking J. B., Kwong S. F., Jones J. H. Pyrazine diuretics II. N-Amidino-3-amino-5-substituted 6-halopyrazinecarboxamides. J. Med. Chem. 1967; 10: 66–75
   PubMed Web of Science ®Google Scholar
• Lohse M. J., Klotz K. N., Lindenborn-Fotinos J., Reddington M., Schwabe U., Olsson R. A. 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) - a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987; 336: 204–210
   Google Scholar
• Bruns R. F., Lu G. H., Pugsley T. A. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol. Pharmacol. 1986; 29: 331–346
   PubMed Web of Science ®Google Scholar
• Timmermans P. B.M.W.M., Karamat Ali F., Kwa H. Y., Schoop A. M. C., Slothorst-Grisdijk F. P., Van Zwieten P. A. Identical antagonist selectivity of central and peripheral α1-adrenoceptors. Mol. Pharmacol. 1981; 20: 295–301
   PubMedGoogle Scholar
• U'Prichard D., Greenberg D. A., Snyder S. H. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol. Pharmacol. 1977; 13: 454–473
   PubMed Web of Science ®Google Scholar
• Nahorski S. R. Heterogeneity of cerebral β-adrenoceptor binding sites in various vertebrate species. Eur. J. Pharmacol. 1978; 51: 199–209
   PubMed Web of Science ®Google Scholar
• Burt D. R., Creese I., Snyder S. H. Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Mol. Pharmacol. 1976; 12: 800–812
   PubMed Web of Science ®Google Scholar
• Creese I., Schneider R., Snyder S. H. 3H-Spiroperidol labels dopamine receptors in pituitary and brain. Eur. J. Pharmacol. 1977; 46: 377–381
   PubMed Web of Science ®Google Scholar
• Gozlan H., El Mestikawy S., Pichat L., Glowinsky J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: [3H]-PAT. Nature 1983; 305: 140–142
   PubMed Web of Science ®Google Scholar
• Sills M. A., Wolfe B. B., Frazer A. Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J. Pharmacol. Exp. Ther. 1984; 231: 480–487
   PubMed Web of Science ®Google Scholar
• Pazos A., Hoyer D., Palacios J. M. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 1985; 106: 539–546
   Google Scholar
• Heuring R. E., Peroutka S. J. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 1987; 7: 894–903
   PubMed Web of Science ®Google Scholar
• Creese I., Snyder S. H. 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur. J. Pharmacol 1978; 49: 201–204
   PubMed Web of Science ®Google Scholar
• Hoyer D., Neijt H. C. Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108–15 neuroblastoma-glioma cells. Eur. J. Pharmacol. 1987; 143: 291–292
   PubMedGoogle Scholar
• Habert E., Graham D., Tahraoui L., Claustre Y., Langer S. Z. Characterization of [3H]paroxetine binding to rat cortical membranes. Eur. J. Pharmacol. 1985; 118: 107–114
   PubMed Web of Science ®Google Scholar
• Tran V. T., Chang R. S. L., Snyder S. H. Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 6290–6294
   PubMed Web of Science ®Google Scholar
• Doods H. N. Affinity and selectivity of muscarinic antagonists for the M1 M2 and M3 binding sites. Characterization and classification of muscarinic receptors and their subtypes (dissertation). University of Amsterdam, Amsterdam 1987; 40–53
   Google Scholar
• Pert C. B., Snyder S. H. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 1974; 10: 868–879
   Web of Science ®Google Scholar
• Hiller J. M., Simon E. J. Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for k receptors. J. Pharmacol. Exp. Ther. 1980; 214: 516–519
   PubMedGoogle Scholar
• Leslie F. M., Chavkin C., Cox B. M. Opioid binding properties of brain and peripheral tissues, evidence for heterogeneity in opioid ligand binding sites. J. Pharmacol. Exp. Ther. 1980; 214: 395–402
   PubMedGoogle Scholar
• Ehlert F. J., Roeske W. R., Itoga E., Yamamura H. I. The binding of [3H]-nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex and ileum of rats. Life Sci. 1982; 30: 2191–2202
   PubMed Web of Science ®Google Scholar
• Reynolds I. J., Snowman A. M., Snyder S. H. [3H]Desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. J. Pharmacol. Exp. Ther. 1986; 237: 731–738
   PubMedGoogle Scholar
• Braestrup C., Squires R. F. Pharmacological characterization of benzodiazepine receptors in the brain. Eur. J. Pharmacol. 1978; 48: 263–270
   PubMedGoogle Scholar
• Herschel M., Baldessarini R. J. Evidence for two types of binding of 3H-GABA and 3H-muscimol in rat cerebral cortex and cerebellum. Life Sci. 1979; 24: 1849–1854
   PubMedGoogle Scholar
• Muller W. E., Snyder S. H. Strychnine binding associated with synaptic glycine receptors in rat spinal cord membranes: ionic influences. Brain Res. 1978; 147: 107–116
   PubMedGoogle Scholar
• Mong S., Wu H. L., Hogaboom G. K., Clark M. A., Crooke S. T. Characterization of the leukotriene D4 receptor in guinea-pig lung. Eur. J. Pharmacol. 1984; 102: 1–11
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Burt D. R. Preparation of 3H-[3-Me-His2]TRH as an improved ligand for TRH receptors. Neuroendocrinol. 1981; 32: 310–316
   PubMedGoogle Scholar
• Van Dijk A., Richards J. G., Trzeciak A., Gillessen D., Möhler H. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H]cholecystokinin-8 as radioligand. J. Neurosci. 1984; 4: 1021–1033
   PubMed Web of Science ®Google Scholar
• Perrone M. H., Diehl R. E., Haubrich D. R. Binding of [3H]Substance P to putative Substance P receptors in rat brain membranes. Eur. J. Pharmacol. 1983; 95: 131–133
   PubMedGoogle Scholar
• Cheng Y. C., Prusoff W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
   PubMed Web of Science ®Google Scholar
• DeLean A. Amiloride potentiates atrial natriuretic factor inhibitory action by increasing receptor binding in bovine adrenal zona glomerulosa. Life Sci. 1986; 39: 1109–1116
   PubMedGoogle Scholar
• Derkach V., Surprenant A., North R. A. 5-HT3 receptors are membrane ion channels. Nature 1989; 339: 706
   PubMed Web of Science ®Google Scholar
• Velly J., Grima M., Decker N., Cragoe E. J., Jr., Schwartz J. Effects of amiloride and its analogues on [3H]batrachotoxinin-A 20-α benzoate binding, [3H]tetracaine binding and 22Na+ influx. Eur. J. Pharmacol. 1988; 149: 97–105
   PubMedGoogle Scholar
• Linden J., Delahunty T. M. Receptors that inhibit phosphoinositide breakdown. Trends Pharmacol. Sci. 1989; 10: 114–120
   PubMed Web of Science ®Google Scholar
• Michell R. Transmembrane signalling. Trend Pharmacol. Sci. 1988; 9, centerfold april
   Google Scholar
• Strange P. G. The structure and mechanism of neurotransmitter receptors. Biochem. J. 1988; 249: 309–318
   PubMed Web of Science ®Google Scholar
• Jean T., Frelin C., Vigne P., Barbry P., Lazdunski M. Biochemical properties of the Na+/H+ exchange system in rat brain synaptosomes. J. Biol. Chem. 1985; 260: 9678–9684
   PubMed Web of Science ®Google Scholar
• Vigne P., Champigny G., Marsault R., Barbry P., Frelin C., Lazdunski M. A new type of amiloride-sensitive cationic channel in endothelial cells of brain microvessels. J. Biol. Chem. 1989; 264: 7663–7668
   PubMedGoogle Scholar
• Garcia M. L., King V. F., Shevell J. L., Slaughter S., Suarez-Kurtz G., Winquist R. J., Kaczorowski G. J. Amiloride analogues inhibit L-type calcium channels and display calcium entry blocker activity. J. Biol Chem. 1990; 265: 3763–3771
   PubMed Web of Science ®Google Scholar
• Horstman D. A., Brandon S., Wilson A. L., Guyer C. A., Cragoe E. J., Jr., Limbird L. E. An aspartate conserved among G-protein receptors confers allosteric regulation of α2-adrenergic receptors by sodium. J. Biol. Chem. 1990; 265: 21590–21595
   PubMed Web of Science ®Google Scholar